Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients

Aim: To evaluate the stability of nitrofurantoin suspended in different extemporaneously compounded vehicles after storage at 4°C and at 25°C. To formulate an effective, readily available vehicle that can guarantee extended stability and precise dosing. Materials and methods: Nitrof...

Full description

Bibliographic Details
Main Authors: Ivaylo Pehlivanov, Stanila Stoeva, Apostol Simitchiev, Stanislav Stefanov, Velichka Andonova
Format: Article
Language:English
Published: Pensoft Publishers 2022-10-01
Series:Folia Medica
Online Access:https://foliamedica.bg/article/72334/download/pdf/
_version_ 1828059426309799936
author Ivaylo Pehlivanov
Stanila Stoeva
Apostol Simitchiev
Stanislav Stefanov
Velichka Andonova
author_facet Ivaylo Pehlivanov
Stanila Stoeva
Apostol Simitchiev
Stanislav Stefanov
Velichka Andonova
author_sort Ivaylo Pehlivanov
collection DOAJ
description Aim: To evaluate the stability of nitrofurantoin suspended in different extemporaneously compounded vehicles after storage at 4°C and at 25°C. To formulate an effective, readily available vehicle that can guarantee extended stability and precise dosing. Materials and methods: Nitrofurantoin was suspended at a concentration of 10 mg/mL in seven different vehicles compounded of different blends of Syrupus simplex, sorbitol 70%, methylcellulose 1%, gummi arabici 1%, gummi xanthani 1%, and sodium carboxymethylcellulose (NaCMC) 1%. Samples of 100 mL of every compounded suspension were stored in dark in graded glass bottles at 4°C and at 25°C. Samples were analyzed at the beginning and every 10 days up to day 30 and every 30 days after. Variations of physical properties such as sedimentation, ease of resuspension, color and odor were evaluated visually and organoleptically. Rheological analysis was also performed in order to determine suspensions’ behavior during storage and dosing. Variations in nitrofurantoin concentration and pH were evaluated with suitable analytical procedure (UV-Vis; HPLC; pH/ORP). Microbiological stability was evaluated via incubation on suitable culture media. Results: To the 30th day, only three of the compounded suspensions exhibited significant physical stability and slight change in taste and odor stored at both temperatures. Two samples stored at 25°C exhibited nitrofurantoin concentration greater than 95% and 4 samples stored at 4°C – concentration greater than 95%. All models showed no microbial growth up to day 30. At 120 days, only three of the compounded suspensions, stored at 4°C, exhibited relatively high nitrofurantoin concentrations: 88.2%, 92%, and 81.1%, respectively. Only one model suspension showed chemical and physical stability (≥95% of the initial concentration) for 102 days. No model suspension remained sterile after 30 days. Conclusions: The suspensions compounded with vehicles of blends of syrups, xanthan, croscarmellose (NaCMC), and sorbitol exhibited low to none sedimentation, good uniformity of content and are suitable organoleptically for pediatric administration. The model suspension stored at 4°C (NTF VII 4°C – with major excipients: sucrose 16%, sorbitol 17%, xanthan gum 0.25%, NaCMC 0.25%) stands out with nitrofurantoin concentration higher than 95% along with no or little signs of sedimentation. After adding a suitable preservative agent or system, a formulation with these characteristics might have an expiration date of at least 90 days.
first_indexed 2024-04-10T21:42:49Z
format Article
id doaj.art-aa601efc9ebe488b8427e756c28246e9
institution Directory Open Access Journal
issn 1314-2143
language English
last_indexed 2024-04-10T21:42:49Z
publishDate 2022-10-01
publisher Pensoft Publishers
record_format Article
series Folia Medica
spelling doaj.art-aa601efc9ebe488b8427e756c28246e92023-01-18T21:09:39ZengPensoft PublishersFolia Medica1314-21432022-10-0164580781610.3897/folmed.64.e7233472334Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patientsIvaylo Pehlivanov0Stanila Stoeva1Apostol Simitchiev2Stanislav Stefanov3Velichka Andonova4Medical University of VarnaMedical University of VarnaUniversity of Food TechnologiesMaychin Dom Medical CenterMedical University of VarnaAim: To evaluate the stability of nitrofurantoin suspended in different extemporaneously compounded vehicles after storage at 4°C and at 25°C. To formulate an effective, readily available vehicle that can guarantee extended stability and precise dosing. Materials and methods: Nitrofurantoin was suspended at a concentration of 10 mg/mL in seven different vehicles compounded of different blends of Syrupus simplex, sorbitol 70%, methylcellulose 1%, gummi arabici 1%, gummi xanthani 1%, and sodium carboxymethylcellulose (NaCMC) 1%. Samples of 100 mL of every compounded suspension were stored in dark in graded glass bottles at 4°C and at 25°C. Samples were analyzed at the beginning and every 10 days up to day 30 and every 30 days after. Variations of physical properties such as sedimentation, ease of resuspension, color and odor were evaluated visually and organoleptically. Rheological analysis was also performed in order to determine suspensions’ behavior during storage and dosing. Variations in nitrofurantoin concentration and pH were evaluated with suitable analytical procedure (UV-Vis; HPLC; pH/ORP). Microbiological stability was evaluated via incubation on suitable culture media. Results: To the 30th day, only three of the compounded suspensions exhibited significant physical stability and slight change in taste and odor stored at both temperatures. Two samples stored at 25°C exhibited nitrofurantoin concentration greater than 95% and 4 samples stored at 4°C – concentration greater than 95%. All models showed no microbial growth up to day 30. At 120 days, only three of the compounded suspensions, stored at 4°C, exhibited relatively high nitrofurantoin concentrations: 88.2%, 92%, and 81.1%, respectively. Only one model suspension showed chemical and physical stability (≥95% of the initial concentration) for 102 days. No model suspension remained sterile after 30 days. Conclusions: The suspensions compounded with vehicles of blends of syrups, xanthan, croscarmellose (NaCMC), and sorbitol exhibited low to none sedimentation, good uniformity of content and are suitable organoleptically for pediatric administration. The model suspension stored at 4°C (NTF VII 4°C – with major excipients: sucrose 16%, sorbitol 17%, xanthan gum 0.25%, NaCMC 0.25%) stands out with nitrofurantoin concentration higher than 95% along with no or little signs of sedimentation. After adding a suitable preservative agent or system, a formulation with these characteristics might have an expiration date of at least 90 days.https://foliamedica.bg/article/72334/download/pdf/
spellingShingle Ivaylo Pehlivanov
Stanila Stoeva
Apostol Simitchiev
Stanislav Stefanov
Velichka Andonova
Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
Folia Medica
title Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
title_full Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
title_fullStr Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
title_full_unstemmed Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
title_short Stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
title_sort stability study of extemporaneously compounded nitrofurantoin oral suspensions for pediatric patients
url https://foliamedica.bg/article/72334/download/pdf/
work_keys_str_mv AT ivaylopehlivanov stabilitystudyofextemporaneouslycompoundednitrofurantoinoralsuspensionsforpediatricpatients
AT stanilastoeva stabilitystudyofextemporaneouslycompoundednitrofurantoinoralsuspensionsforpediatricpatients
AT apostolsimitchiev stabilitystudyofextemporaneouslycompoundednitrofurantoinoralsuspensionsforpediatricpatients
AT stanislavstefanov stabilitystudyofextemporaneouslycompoundednitrofurantoinoralsuspensionsforpediatricpatients
AT velichkaandonova stabilitystudyofextemporaneouslycompoundednitrofurantoinoralsuspensionsforpediatricpatients